Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 5, 2014
    OPDP Director Outlines Social Media Plans, Promises Next Guidance on Topic Coming ‘Soon'
  • Feb 25, 2014
    Endo Settles Off-label Promotion Allegations For $192.7 Million, Deferred Prosecution
  • Feb 18, 2014
    FDA Study To Examine Impact on Consumers of Shortened Risk Information in DTC TV Ads
  • Feb 12, 2014
    CMS Tweaks Deadline for Reporting Payments To Physicians, Reporting Now Will Be Phased In
  • Feb 3, 2014
    CDER’s 2014 Agenda Includes Three Social Media Guidances, Revisions to Print and TV DTC Documents
  • Jan 31, 2014
    OPDP Webinar Elicits Host of Substantiation Questions
  • Jan 28, 2014
    Untitled Letter Hits Company Over Promotional Claims in Sales Sheet
  • Jan 24, 2014
    FDA Tweaks Guidance on Letters to Physicians, Adds Elements for Corrective Advertising Alerts
  • Jan 16, 2014
    $40.1 Million Settlement Resolves Kickback, Off-label Marketing Allegations Against CareFusion Corp.
  • Jan 14, 2014
    FDA Guidance Draws Distinctions Between Beverages, Supplements In Effort To Rein in Energy Drinks
  • More

Good Clinical Practice

  • Feb 18, 2016
    Connecticut House Committee Introduces ‘Right-to-Try’ Bill
  • Feb 16, 2016
    ‘Persistent’ Under-representation of Women Found in HIV Clinical Trials
  • Feb 16, 2016
    House Committee Introduces ‘Right-to-Try’ Bill in Idaho
  • Feb 10, 2016
    Bill Approved by Senate HELP Committee Paves Way for Single IRB Device Review
  • Feb 10, 2016
    FDA Hosts Workshop on TBI Biomarkers March 3
  • Feb 9, 2016
    Assembly Bill Calls for California Cancer Clinical Trials Program
  • Feb 9, 2016
    ACRO Releases ‘Real World Data' Videos
  • Feb 6, 2016
    French Minister Calls for EC Panel To Strengthen Phase 1 Subject Protections
  • Feb 6, 2016
    Human Factors Validation Studies Must Be Conducted Before Clinical Studies for Device Combo Products
  • Feb 4, 2016
    ACRES, GuideStar Collaborate on Site Sustainability, Accreditation Oversight
  • More

FDA Regulation & Enforcement

  • Nov 20, 2018
    FDA, USDA Agree To Share Regulation of Cell Cultured Food Products, Extend Time To Comment
  • Nov 19, 2018
    Grassley, Durbin Request GAO Examination of DTC Ads’ Impact on Medicare Spending
  • Nov 16, 2018
    Civil Forfeiture Action Targets Kratom-Containing Supplements at South Carolina Distributor’s Facility
  • Nov 15, 2018
    FDA Moving Ahead with Research on Scientific and Clinical Data Disclosures for Oncology Promotions
  • Nov 14, 2018
    FDA: New Protocols for Aseptic Processing Facility Inspections Focus on Product Quality, Increase Consistency
  • Nov 14, 2018
    Kentucky Appeals Court Affirms Dismissal of State Law Tort Claims Against Maker of Class III IDE Device on Preemption Grounds
  • Nov 14, 2018
    Groups Ask Court To Stop Enforcement of Missouri ‘Meat’ Labeling Law
  • Nov 14, 2018
    New Jersey Sues Janssen Over Opioid Marketing
  • Nov 13, 2018
    Appeals Court Finds Homeopathic Company’s Claims Were Not Misleading or Deceptive
  • Nov 12, 2018
    American Society for Aesthetic Plastic Surgery Add Industry Partnerships
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.